Yearly Long-Acting Zoledronic Acid (Reclast) Is Safe And Effective For Treatment Of Bone Loss After Hematopoietic Stem Cell TransplantationZhuoyan Li,Samuel M Rubinstein,Carey Clifton,Leigh Ann Vaughan, Melissa Logue,Michael T. Byrne,Adetola A. Kassim,Brian G Engelhardt,Wichai Chinratanalab,Salyka Sengsayadeth,Stephen J. Brandt,Stacey A. Goodman,John P. Greer,Madan Jagasia,Bipin N. SavaniBLOOD(2016)引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要